Writers urge improvements to C&J bus service, seek voter support and weigh in on President Trump's first two weeks in office.

Twenty-five years ago, the bestseller “The Tipping Point” turned Malcolm Gladwell into a household name. Describing “the critical mass, the threshold, the boiling point,” Gladwell illustrates his ...

Purdue has sold a Narcan alternative since 2022 and Hikma has developed an opioid antagonist twice the dose of Narcan.

Sen. Mike Yakawich's bill to prohibit the state from buying overdose reversal drugs from companies that settled with states ...

Billings, compares the state’s purchase of overdose reversal drugs like Narcan from companies that have contributed to the ...

Public health experts have concerns about the opioid reversal agent Opvee. But the company that makes it, Indivior, has found ...

Pfizer Settles Its Subsidiary’s Kickback Allegations for Nearly $60 Million - Pfizer Inc. agreed to pay over $59,746,277 to ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll ...

Rockville Centre became the first diocese in New York with a confirmed reorganization plan, providing a potential blueprint ...

A Williamsburg-based recovery advocate said she hopes the money will help local families and communities impacted by the crisis.

Pennsylvania looks likely to receive another big infusion of money from another court settlement over responsibility for the nation’s ongoing opioid epidemic.

FDA approves non-opioid pain reliever, suzetrigine, by Vertex Pharmaceuticals to mitigate risks of opioids and provide patients with more options.